Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have used cells from sarcoma patients to develop the ...

Investigators developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to ...

A UCLA team created a biobank of sarcoma organoids from 126 patients, enabling rapid drug screening. The organoids retained ...

Gut stem cell-derived organoids have uncovered two molecular subtypes of Crohn’s disease, offering hope for personalized ...

In this edition of the biotech bi-weekly, a new partnership takes vascularized organoids to the international space station ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient ...

The following is a summary of “Radiation response assessment of organoids derived from patients with pancreatic cancer,” published in the September 2024 issue of Oncology by Goor et al. The ...

Pancreatic cancer is one of the deadliest cancers worldwide. A promising technology poised to advance treatment is organoids, ...

Bladder cancer (BLCa) remains a prevalent malignancy with high recurrence rates and limited treatment options. In recent years, patient-derived organoids (PDOs) have emerged as a promising platform ...